Yuji Teraoka

1.3k total citations
26 papers, 418 citations indexed

About

Yuji Teraoka is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Yuji Teraoka has authored 26 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Yuji Teraoka's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (8 papers). Yuji Teraoka is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis B Virus Studies (8 papers). Yuji Teraoka collaborates with scholars based in Japan, United States and Australia. Yuji Teraoka's co-authors include Kazuaki Chayama, Michio Imamura, Hiroshi Aikata, Masataka Tsuge, Takashi Nakahara, Tomokazu Kawaoka, Akira Hiramatsu, Kei Morio, Yuko Nagaoki and Yoshiiku Kawakami and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuji Teraoka

22 papers receiving 407 citations

Peers

Yuji Teraoka
Dimitris Zacharoulis Greece
Jean‐Yves Mabrut France
Isabelle Ollivier France
J Paris France
P. Audet Canada
M Katsuragi Japan
Eitaro Hiejima Japan
O. Farges France
Giorgia Ghittoni Italy
Satoshi Itano Japan
Dimitris Zacharoulis Greece
Yuji Teraoka
Citations per year, relative to Yuji Teraoka Yuji Teraoka (= 1×) peers Dimitris Zacharoulis

Countries citing papers authored by Yuji Teraoka

Since Specialization
Citations

This map shows the geographic impact of Yuji Teraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Teraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Teraoka more than expected).

Fields of papers citing papers by Yuji Teraoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Teraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Teraoka. The network helps show where Yuji Teraoka may publish in the future.

Co-authorship network of co-authors of Yuji Teraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Teraoka. A scholar is included among the top collaborators of Yuji Teraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Teraoka. Yuji Teraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhensheng, Yuji Teraoka, Jason Piotrowski, et al.. (2025). Hepatitis B virus genotypes A1 and A2 have distinct replication phenotypes due to polymorphisms in the HBx gene. PLoS Pathogens. 21(1). e1012803–e1012803. 1 indexed citations
2.
Yamaguchi, Atsushi, Hiroki Kamada, Naohiro Kato, et al.. (2025). Real-world effectiveness of anamorelin in patients with unresectable and relapse pancreatic cancer: a prospective observational study. Journal of Gastrointestinal Oncology. 16(3). 1268–1279.
3.
Yamaguchi, Atsushi, Hiroki Kamada, Naohiro Kato, et al.. (2025). Metastatic pancreatic acinar cell carcinoma with BRCA2 gene alternation resected after modified FORFIRINOX therapy: a case report and literature review. Journal of Gastrointestinal Oncology. 16(2). 726–737.
4.
Miki, Daiki, C. Nelson Hayes, Yuji Teraoka, et al.. (2024). Multi-omics analysis of a fatty liver model using human hepatocyte chimeric mice. Scientific Reports. 14(1). 3362–3362. 5 indexed citations
5.
Zhang, Zhensheng, Michio Imamura, Yuji Teraoka, et al.. (2021). Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models. Journal of Hepatology. 75(6). 1335–1345. 23 indexed citations
6.
Fujii, Yasutoshi, Atsushi Ono, C. Nelson Hayes, et al.. (2021). Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib. Journal of Experimental & Clinical Cancer Research. 40(1). 215–215. 32 indexed citations
7.
Shimomura, Yumi, Michio Imamura, Yuji Teraoka, et al.. (2021). Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients. Journal of Infection. 84(3). 391–399. 4 indexed citations
8.
9.
Murakami, Eisuke, Takashi Nakahara, Kazuki Ohya, et al.. (2020). In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism. Molecular Medicine Reports. 23(1). 6 indexed citations
10.
Ohya, Kazuki, Michio Imamura, Yuji Teraoka, et al.. (2019). Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy. Clinical Journal of Gastroenterology. 13(2). 267–270. 3 indexed citations
11.
12.
Teraoka, Yuji, Takuro Uchida, Michio Imamura, et al.. (2018). Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice. Biochemical and Biophysical Research Communications. 500(2). 152–157. 10 indexed citations
13.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2018). Primary hepatic follicular lymphoma: A case report. Kanzo. 59(3). 162–170.
14.
Honda, Fumi, Akira Hiramatsu, Hideyuki Hyogo, et al.. (2018). Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring. PLoS ONE. 13(4). e0195028–e0195028. 43 indexed citations
15.
Kawaoka, Tomokazu, Hiroshi Aikata, Yuji Teraoka, et al.. (2017). Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib. Oncology. 92(6). 335–346. 11 indexed citations
16.
Morio, Kei, Michio Imamura, Yuji Teraoka, et al.. (2017). Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. Journal of Gastroenterology. 52(12). 1252–1257. 24 indexed citations
17.
Nakamura, Yuki, Michio Imamura, Yoshiiku Kawakami, et al.. (2016). Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction. Journal of Medical Virology. 89(4). 665–671. 6 indexed citations
18.
Imagawa, Hiroki, Juri Ikemoto, Yuji Teraoka, et al.. (2015). A Trial of the Use of Patency Capsules in Combination with Overnight Capsule Endoscopy. Digestion. 91(1). 46–49. 2 indexed citations
19.
Morimoto, Hiroshi, Kohei Ishiyama, Masahiro Ohira, et al.. (2014). Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus. Transplantation Proceedings. 46(3). 770–773. 6 indexed citations
20.
Hanada, Keiji, Akihito Okazaki, Yoshihiro Izumi, et al.. (2014). Diagnostic strategies for early pancreatic cancer. Journal of Gastroenterology. 50(2). 147–154. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitris Zacharoulis Breakdown of academic impact, for papers by Jean‐Yves Mabrut Breakdown of academic impact, for papers by Isabelle Ollivier Breakdown of academic impact, for papers by J Paris Breakdown of academic impact, for papers by P. Audet Breakdown of academic impact, for papers by M Katsuragi Breakdown of academic impact, for papers by Eitaro Hiejima Breakdown of academic impact, for papers by O. Farges Breakdown of academic impact, for papers by Giorgia Ghittoni Breakdown of academic impact, for papers by Satoshi Itano
Rankless by CCL
2026